Correction: Activation of RAS/MAPK pathway confers MCL-1 mediated acquired resistance to BCL-2 inhibitor venetoclax in acute myeloid leukemia.
Qi ZhangBridget Riley-GillisLina HanYannan JiaAlessia LodiHaijiao ZhangSaravanan GanesanRongqing PanSergej N KonoplevShannon R SweeneyJeremy Adam RyanYulia JitkovaKenneth DunnerShaun E GrosskurthPriyanka VijaySujana GhoshCharles LuWencai MaStephen KurtzVivian R RuvoloHelen MaConnie C WengCassandra L RamageNatalia BaranCe ShiTianyu CaiRichard Eric DavisVenkata Lokesh BattulaYingchang MiJing WangCourtney D DiNardoMichael AndreeffJeffery W TynerAaron SchimmerAnthony G LetaiRose Ann PaduaCarlos E Bueso-RamosStefano TizianiJoel LeversonRelja PopovicMarina KonoplevaPublished in: Signal transduction and targeted therapy (2022)